A Tumorigenic Factor Interactome Connected through Tumor Suppressor MicroRNA-198 in Human Pancreatic Cancer

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Clinical Cancer Research

• Publication date

  2013-08-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-12-3776PMID 23989979PMCID PMC3920728
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression

  2011cited by this paper
• miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1

  2011cited by this paper
• miR‐198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c‐MET pathway

  2011cited by this paper
• Mesothelin overexpression promotes autocrine IL-6/sIL-6R trans-signaling to stimulate pancreatic cancer cell proliferation.

  2010cited by this paper
• A high throughput embryonic stem cell screen identifies Oct-2 as a bifunctional regulator of neuronal differentiation.

  2009cited by this paper
• miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.

  2009cited by this paper
• Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer

  2008cited by this paper
• MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation

  2008cited by this paper
• Identification of Pbx1, a potential oncogene, as a Notch3 target gene in ovarian cancer.

  2008cited by this paper
• Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis

  2008cited by this paper
• Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression.

  2008cited by this paper
• Mesothelin-Induced Pancreatic Cancer Cell Proliferation Involves Alteration of Cyclin E via Activation of Signal Transducer and Activator of Transcription Protein 3

  2008cited by this paper
• MicroRNA gene expression profile of hepatitis C virus–associated hepatocellular carcinoma

  2007cited by this paper
• Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression

  2007cited by this paper
• EXPRESSION OF NESTIN IN PANCREATIC CANCER CORRELATES WITH OF INVASIVE ABILITY

  2007cited by this paper
• Pre-B-cell leukemia transcription factor 1 regulates expression of valosin-containing protein, a gene involved in cancer growth.

  2007cited by this paper
• Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.

  2005cited by this paper
• Expression level of valosin-containing protein (VCP) as a prognostic marker for gingival squamous cell carcinoma.

  2004cited by this paper
• Expression Level of Valosin-Containing Protein (p97) Is Associated with Prognosis of Esophageal Carcinoma

  2004cited by this paper
• Valosin-Containing Protein (p97) and Ki-67 Expression Is a Useful Marker in Detecting Malignant Behavior of Pancreatic Endocrine Neoplasms

  2004cited by this paper
• Elevated Expression of Valosin-Containing Protein (p97) Is Associated with Poor Prognosis of Prostate Cancer

  2004cited by this paper
• Molecular perspectives on p97-VCP: progress in understanding its structure and diverse biological functions.

  2004influential reference
• Identification of mammalian microRNA host genes and transcription units.

  2004cited by this paper
• The human involucrin gene is transcriptionally repressed through a tissue-specific silencer element recognized by Oct-2.

  2004cited by this paper
• Expression of Valosin-Containing Protein in Colorectal Carcinomas as a Predictor for Disease Recurrence and Prognosis

  2004cited by this paper
• Increased Expression of Valosin-Containing Protein (p97) is Associated With Lymph Node Metastasis and Prognosis of Pancreatic Ductal Adenocarcinoma

  2004cited by this paper
• Transcription and processing of human microRNA precursors.

  2004cited by this paper
• Characterization of human mesothelin transcripts in ovarian and pancreatic cancer

  2004cited by this paper
• VCP (p97) Regulates NFKB Signaling Pathway, Which Is Important for Metastasis of Osteosarcoma Cell Line

  2002cited by this paper
• Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).

  2001cited by this paper
• PDX:PBX complexes are required for normal proliferation of pancreatic cells during development.

  2001cited by this paper
• In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice.

  1999cited by this paper
• Pbx-Hox Heterodimers Recruit Coactivator-Corepressor Complexes in an Isoform-Specific Manner

  1999cited by this paper
• From molecular to modular cell biology

  1999cited by this paper
• P-selectin expression in a metastatic pancreatic tumor cell line (SUIT-2).

  1997cited by this paper
• Transcription Factor NF-κB Regulates Inducible Oct-2 Gene Expression in Precursor B Lymphocytes*

  1997cited by this paper
• High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells.

  1996cited by this paper
• Transcriptional activation and repression, two properties of the lymphoid-specific transcription factor Oct-2a.

  1995cited by this paper

• POU2F2+ B cells enhance antitumor immunity and predict better survival in non small cell lung cancer

  2025cites this paper
• Decoding the role of mesothelin in tumor dynamics and targeted treatment innovations

  2025cites this paper
• CircRNA_0004104 Participates in Regulating Trophoblast Invasion, Migration and Oxidative Stress in Pre‐eclampsia Through microRNA‐198

  2025cites this paper
• Blocking CCR1+ macrophages overcomes resistance to immune checkpoint inhibitors in melanoma

  2025cites this paper
• Mechanisms and progress of LncRNAs in prostate cancer development and diagnostic therapy

  2025cites this paper
• Mesothelin as a Signal Pathways and Epigenetic Target in Cancer Therapy

  2025cites this paper
• VCP Promotes Cholangiocarcinoma Development by Mediating BAP1 Ubiquitination‐Dependent Degradation

  2025cites this paper
• Pick-up single-cell proteomic analysis for quantifying up to 3000 proteins in a Mammalian cell

  2024cites this paper
• Excess shed mesothelin disrupts pancreatic cancer cell clustering to impair peritoneal colonization

  2024cites this paper
• Comprehensive summary: the role of PBX1 in development and cancers

  2024cites this paper
• Developing of Pharmacophore and Three-Dimensional Structure-Activity Relationship Models of VCP/p97 Ligands and Their Synthesis and Biological Evaluation

  2024cites this paper
• Macrophages Under the Influence of Tumor Mesothelin Weaken Host Defenses against Pancreatic Cancer Metastasis.

  2024cites this paper
• Identifying molecular subtypes and tumor microenvironment infiltration signatures in kidney renal clear cell carcinoma based on stemness-associated disulfidptosis genes by integrating machine learning, single-cell analyses and experimental validation

  2024cites this paper
• PBX1 as a novel master regulator in cancer: Its regulation, molecular biology, and therapeutic applications.

  2024cites this paper
• EBV and 1q Gains Affect Gene and miRNA Expression in Burkitt Lymphoma

  2023cites this paper
• Functional and Potential Therapeutic Implication of MicroRNAs in Pancreatic Cancer

  2023cites this paper
• High Mesothelin expression in pancreatic adenocarcinoma is associated with aggressive tumor features but not prognosis.

  2023cites this paper
• Biology of Mesothelin and Clinical Implications: A Review of Existing Literature

  2023cites this paper
• Microbiome and MicroRNA or Long Non-Coding RNA—Two Modern Approaches to Understanding Pancreatic Ductal Adenocarcinoma

  2023cites this paper
• Nanoparticle-Mediated Therapy with miR-198 Sensitizes Pancreatic Cancer to Gemcitabine Treatment through Downregulation of VCP-Mediated Autophagy

  2023influential citation
• The regulation of PBXs and their emerging role in cancer

  2022cites this paper
• Circulating MicroRNAs as Noninvasive Diagnostic and Prognostic Biomarkers in Pancreatic Cancer: A Review

  2022cites this paper
• The promising role and prognostic value of miR-198 in human diseases.

  2022cites this paper
• The Roles of MicroRNA in Pancreatic Cancer Progression

  2022influential citation
• Mesothelin: An Immunotherapeutic Target beyond Solid Tumors

  2022cites this paper
• Selective and sensitive detection of miRNA-198 using single polymeric microfiber waveguide platform with heterogeneous CHA amplification strategy.

  2022cites this paper
• Long Non-Coding RNA ARAP1-AS1 Facilitates the Progression of Cervical Cancer by Regulating miR-149-3p and POU2F2

  2021cites this paper
• Emerging role and function of miR-198 in human health and diseases.

  2021cites this paper
• Hsa_circ_0074032 promotes prostate cancer progression through elevating homeobox A1 expression by serving as a microRNA‐198 decoy

  2021cites this paper
• HOXA3-Induced Exosomal lncRNA RNF144A-AS1 Promotes Liver Metastasis of Gastric Cancer via Interacting with PUF60 Protein and Sponging miR-361-3p

  2021cites this paper
• Monoamine Oxidase (MAO) as a Potential Target for Anticancer Drug Design and Development

  2021cites this paper
• Two Antibody-Guided Lactic-co-Glycolic Acid-Polyethylenimine (LGA-PEI) Nanoparticle Delivery Systems for Therapeutic Nucleic Acids

  2021cites this paper
• Valosin-Containing Protein (VCP)/p97: A Prognostic Biomarker and Therapeutic Target in Cancer

  2021cites this paper
• POU2F2‐IL‐31 Autoregulatory Circuit Converts Hepatocytes into the Origin Cells of Hepatocellular Carcinoma

  2021cites this paper
• POU2F2 regulates glycolytic reprogramming and glioblastoma progression via PDPK1-dependent activation of PI3K/AKT/mTOR pathway

  2021cites this paper
• Identification of pancreatic cancer type related factors by Weighted Gene Co-Expression Network Analysis

  2020cites this paper
• Prognostic value of microRNAs in pancreatic cancer: a meta-analysis

  2020cites this paper
• Circular RNA LPAR3 sponges microRNA‐198 to facilitate esophageal cancer migration, invasion, and metastasis

  2020cites this paper
• From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma

  2020cites this paper
• Impact of mirna-21 on survival prognosis in patients with pancreatic cancer

  2020cites this paper
• Mechanistic Actions of microRNAs in Diabetic Wound Healing

  2020cites this paper
• Speratum: Building a Life Science Startup in Costa Rica

  2020cites this paper
• Oncogenic and tumor suppressor function of MEIS and associated factors

  2020cites this paper
• Comprehensive epigenetic analyses reveal master regulators driving lung metastasis of breast cancer

  2019cites this paper
• Clinical value of microRNA-198-5p downregulation in lung adenocarcinoma and its potential pathways

  2019cites this paper
• Mesothelium-derived factors shape tissue resident macrophage

  2019cites this paper
• Mesothelin Enhances Tumor Vascularity in Newly Forming Pancreatic Peritoneal Metastases

  2019influential citation
• MicroRNA-198 suppresses prostate tumorigenesis by targeting MIB1

  2019cites this paper
• Clinical and prognostic significance of hypercoagulability in patients with metastatic colorectal cancer

  2019cites this paper
• Cancer: the dark side of wound healing

  2018cites this paper
• Network analyses–based identification of circular ribonucleic acid–related pathways in intrahepatic cholangiocarcinoma

  2018cites this paper
• Patent highlights from December 2017 to January 2018.

  2018cites this paper
• Long Noncoding RNA SChLAP1 Accelerates the Proliferation and Metastasis of Prostate Cancer via Targeting miR-198 and Promoting the MAPK1 Pathway

  2018cites this paper
• Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR

  2018cites this paper
• The Role of Mesothelin as a Diagnostic and Therapeutic Target in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review

  2018cites this paper
• MiR-103 a-3 p targets the 5 ' UTR of GPRC 5 A in pancreatic cells

  2018cites this paper
• miR-198 functions as a tumor suppressor in breast cancer by targeting CUB domain-containing protein 1.

  2017cites this paper
• miR-639在骨髓增生异常综合征中的表达及其靶基因预测

  2017cites this paper
• Identification of MiR-21-5p as a Functional Regulator of Mesothelin Expression Using MicroRNA Capture Affinity Coupled with Next Generation Sequencing

  2017cites this paper
• Cancer Genetics at a Glance: The Comprehensive Insights

  2017cites this paper
• MicroRNA profiles during galectin-9-induced apoptosis of pancreatic cancer cells.

  2017cites this paper
• Prognostic value of microRNA expression levels in pancreatic adenocarcinoma: a review of the literature

  2017cites this paper
• Decreased microRNA-198 expression and its prognostic significance in human glioma.

  2016cites this paper
• Mesothelin Immunotherapy for Cancer: Ready for Prime Time?

  2016cites this paper
• Anticancer Effects of Mesothelin-Targeted Immunotoxin Therapy Are Regulated by Tyrosine Kinase DDR1.

  2016cites this paper
• Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application

  2016cites this paper
• Lower expressed miR-198 and its potential targets in hepatocellular carcinoma: a clinicopathological and in silico study

  2016influential citation
• Decreased miR-198 expression and its prognostic significance in human gastric cancer

  2016cites this paper
• MicroRNAs as biomarkers and prospective therapeutic targets in colon and pancreatic cancers

  2015cites this paper
• MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma

  2015cites this paper
• p75NTR-dependent activation of NF-κB regulates microRNA-503 transcription and pericyte–endothelial crosstalk in diabetes after limb ischaemia

  2015cites this paper
• Identification of miRNA-mRNA crosstalk in pancreatic cancer by integrating transcriptome analysis.

  2015cites this paper
• Galectin-9 suppresses cholangiocarcinoma cell proliferation by inducing apoptosis but not cell cycle arrest.

  2015cites this paper
• miR-198 Represses the Proliferation of HaCaT Cells by Targeting Cyclin D2

  2015cites this paper
• POU2F2-oriented network promotes human gastric cancer metastasis

  2015cites this paper
• microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis.

  2015cites this paper
• Molecular Imaging with MRI: Potential Application in Pancreatic Cancer

  2015cites this paper
• MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancer.

  2014cites this paper
• MiR-103a-3p targets the 5′ UTR of GPRC5A in pancreatic cells

  2014cites this paper
• MiR-371-5p Facilitates Pancreatic Cancer Cell Proliferation and Decreases Patient Survival

  2014cites this paper
• MiR-198 represses tumor growth and metastasis in colorectal cancer by targeting fucosyl transferase 8

  2014cites this paper
• Interrelationships of circulating tumor cells with metastasis and thrombosis: role of microRNAs.

  2014cites this paper
• Advances in pancreatic cancer research: moving towards early detection.

  2014cites this paper
• Pathology, genetic alterations, and targets of differentially expressed microRNAs in pancreatic cancer

  2014cites this paper
• miR-1247 is correlated with prognosis of pancreatic cancer and inhibits cell proliferation by targeting neuropilins.

  2014cites this paper
• Aberrant MicroRNAs in Pancreatic Cancer: Researches and Clinical Implications

  2014cites this paper
• MIR-198 IN PANCREATIC CANCER PROGRESSION AND MANAGEMENT By OLORUNSEUN OLATUNJI OGUNWOBI A THESIS PRESENTED TO THE GRADUATE SCHOOL OF THE UNIVERSITY OF FLORIDA IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE UNIVERSITY OF FLORIDA

  2013cites this paper